BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17302034)

  • 1. [Inhibition activity of semenogelin and its peptides to human spermatozoa].
    Wang ZJ; Zhang W; Wu HF; Xu YG
    Zhonghua Nan Ke Xue; 2007 Jan; 13(1):42-5. PubMed ID: 17302034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Procaryotic expression, purification and identification of recombinant human prostate-specific antigen].
    Wang ZJ; Zhang W; Wu HF; Sui YG
    Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1080-3. PubMed ID: 18284054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process.
    de Lamirande E; Yoshida K; Yoshiike TM; Iwamoto T; Gagnon C
    J Androl; 2001; 22(4):672-9. PubMed ID: 11451365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of recombinant human semenogelin as an inhibitor of human sperm motility.
    Mitra A; Richardson RT; O'Rand MG
    Biol Reprod; 2010 Mar; 82(3):489-96. PubMed ID: 19889947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semenogelin, the main protein of the human semen coagulum, regulates sperm function.
    de Lamirande E
    Semin Thromb Hemost; 2007 Feb; 33(1):60-8. PubMed ID: 17253191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans.
    Yoshida K; Kawano N; Yoshiike M; Yoshida M; Iwamoto T; Morisawa M
    Mol Hum Reprod; 2008 Mar; 14(3):151-6. PubMed ID: 18203809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large deletion of the repeat site in semenogelin I is not involved in male infertility.
    Miyano S; Yoshida K; Yoshiike M; Miyamoto C; Furuichi Y; Iwamoto T
    Int J Mol Med; 2003 Apr; 11(4):435-40. PubMed ID: 12632094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of eppin with semenogelin on human spermatozoa.
    Wang Z; Widgren EE; Sivashanmugam P; O'Rand MG; Richardson RT
    Biol Reprod; 2005 May; 72(5):1064-70. PubMed ID: 15590901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GPI-anchored CD52 antigen of the sperm surface interacts with semenogelin and participates in clot formation and liquefaction of human semen.
    Flori F; Ermini L; La Sala GB; Nicoli A; Capone A; Focarelli R; Rosati F; Giovampaola CD
    Mol Reprod Dev; 2008 Feb; 75(2):326-35. PubMed ID: 17624925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of recombinant precursor proteins of the human seminal plasma sperm motility inhibitor synthesized in insect cells.
    Murakami J; Yoshiike M; Satoh M; Furuichi Y; Iwamoto T
    Int J Mol Med; 1998 Dec; 2(6):693-700. PubMed ID: 9850738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activities of the fragments of semenogelin I: an update].
    Hu C; Zhao H
    Zhonghua Nan Ke Xue; 2013 Feb; 19(2):169-72. PubMed ID: 23441461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation of low-molecular-mass antibacterial mixtures from human seminal plasma].
    Zhao H; Shen JH; Li WH; Zhang Y; Li H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):842-6. PubMed ID: 19024329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel semenogelin I-derived antimicrobial peptide from liquefied human seminal plasma.
    Zhao H; Lee WH; Shen JH; Li H; Zhang Y
    Peptides; 2008 Apr; 29(4):505-11. PubMed ID: 18314226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the study of Semenogelin I from human seminal vesicles].
    Su SF; Wang ZJ
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):364-6. PubMed ID: 19472915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human sperm motility by contraceptive anti-eppin antibodies from infertile male monkeys: effect on cyclic adenosine monophosphate.
    O'Rand MG; Widgren EE; Beyler S; Richardson RT
    Biol Reprod; 2009 Feb; 80(2):279-85. PubMed ID: 18945989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of epididymal protease inhibitor modulating the liquefaction of human semen.
    Wang ZJ; Zhang W; Feng NH; Song NH; Wu HF; Sui YG
    Asian J Androl; 2008 Sep; 10(5):770-5. PubMed ID: 18645681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Semenogelin and sperm motility inhibition: an update].
    Yi C; He RS; Zhao H; Hao LN
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):1023-6. PubMed ID: 21218648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of seminal plasma motility inhibitor/semenogelin in human seminal plasma.
    Yoshida K; Yamasaki T; Yoshiike M; Takano S; Sato I; Iwamoto T
    J Androl; 2003; 24(6):878-84. PubMed ID: 14581514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin.
    Robert M; Gagnon C
    Biol Reprod; 1996 Oct; 55(4):813-21. PubMed ID: 8879494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of semenogelin in human spermatozoa decrease during capacitation: involvement of reactive oxygen species and zinc.
    de Lamirande E; Lamothe G
    Hum Reprod; 2010 Jul; 25(7):1619-30. PubMed ID: 20501468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.